TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Biovica International AB
Closing information (x1000 SEK)
| Closing information | 2024/04 (consolidated) | 2023/04 (consolidated) | 2022/04 (consolidated) |
| Turnover |
7,290
|
3,383
|
2,045 |
| Financial expenses |
289
|
493
|
79 |
| Earnings before taxes |
-124,136
|
-110,680
|
-59,991 |
| EBITDA |
-117,416
|
-102,243
|
-53,662 |
| Total assets |
131,408
|
172,288
|
151,631 |
| Current assets |
88,115
|
119,990
|
94,914 |
| Current liabilities |
28,291
|
23,638
|
16,094 |
| Equity capital |
96,641
|
138,636
|
124,088 |
| - share capital |
5,604
|
3,049
|
1,899 |
| Employees (average) |
37
|
31
|
25 |
Financial ratios
| Fiscal year | 2024/04 (consolidated) | 2023/04 (consolidated) | 2022/04 (consolidated) |
| Solvency |
73.5%
|
80.5%
|
81.8% |
| Turnover per employee |
197
|
109
|
82 |
| Profit as a percentage of turnover |
-1702.8%
|
-3271.7%
|
-2933.5% |
| Return on assets (ROA) |
-94.2%
|
-64.0%
|
-39.5% |
| Current ratio |
311.5%
|
507.6%
|
589.7% |
| Return on equity (ROE) |
-128.5%
|
-79.8%
|
-48.3% |
| Change turnover |
3,907
|
1,338
|
-32 |
| Change turnover % |
115%
|
65%
|
-2% |
| Chg. No. of employees |
6
|
6
|
5 |
| Chg. No. of employees % |
19%
|
24%
|
25% |
Total value of public sale
| Fiscal year | 2024/04 (consolidated) | 2023/04 (consolidated) | 2022/04 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.